drugset

drugset / Trial / NCT03831334

Effect of Low-Dose Oral Minoxidil as Treatment of Permanent Chemotherapy-Induced Alopecia

NCT03831334 ↗

Phase 0 Active not recruiting 14 enrolled Northwestern University

NaSingle-groupOpen-labelTreatment

Summary

An open label, pilot study involving the use of low dose oral minoxidil to treat permanent chemotherapy-induced alopecia.

Timeline

Start: 2019-04-09
Primary completion: 2024-01-24
Completion: 2026-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Minoxidil	Small molecule	1.25 mg	Oral

Indications